NPT100-18A
NPT100-18A is an αSyn oligomerization inhibitor. NPT10018A rescues cleaved caspase-3 levels to control levels. NPT10018A attenuates mitochondrial oxidative stress probe levels in a compartment-specific manner and, at higher concentrations, increases ATP signals. NPT100-18A can be used for the study of Parkinson’s disease (PD).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C28H39N5O3
- 分子量:493.64
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
IC50 & Target
|
Caspase 3 |
体外実験
NPT100-18A (10 nM) reduces the amount of Triton-X100 insoluble αSyn aggregated conformers in iPSC-derived mDANs[1].
NPT100-18A (10 nM) specifically reduces mitochondrial ROS in iPSC-derived mDANs without affecting total intracellular ROS[1].
NPT100-18A (1 µM) significantly increases ATP signaling in iPSC-derived mDANs[1].
NPT100-18A (10 nM, 21 days) significantly reduces the proportion of cCasp3⁺ neurons in iPSC-derived mDANs and inhibits the αSyn-related early neuronal apoptosis pathway[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:mThy1-wt-α-syn transgenic mice[2].
-
Dosage:1 mg/kg, 5 mg/kg, 10 mg/kg, 20 mg/kg
-
Administration:I.p., once daily for 90 days
-
Result:10 and 20 mg/kg significantly reduced foot slips.
10 mg/kg significantly improved the error rate in the Challenger beam test.
Accumulation of α-synuclein in neurons and neurites was reduced.
SDS-resistant α-synuclein oligomers were reduced.
α-synuclein changed from a membrane component to a cytoplasmic component.
-
Animal Model:mThy1-E57K-α-syn transgenic mice[2].
-
Dosage:20 mg/kg
-
Administration:I.p., once daily for 90 days
-
Result:Significantly reduced α-syn dimer/trimer/polymers.
Oligomer accumulation decreased markedly.
化学情報
-
分子量 493.64
-
分子式 C28H39N5O3
-
SMILES
O=C1N(CC2CCNCC2)CC(N(C(CCC3=CNC4=C3C=CC=C4)=O)CCC5=O)N5C1CCCC
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Alecu JE, et al. NPT100-18A rescues mitochondrial oxidative stress and neuronal degeneration in human iPSC-based Parkinson's model. BMC Neurosci. 2025 Jan 28;26(1):8. [Content Brief]
[2]. Wrasidlo W, et al. A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease. Brain. 2016 Dec;139(Pt 12):3217-3236. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
NPT100-18A 関連分類
HY-156898 関連分類
Powered by Bioz